Presentation Information

[F1-33]Presenting MHC II determines fidelity of SARS-CoV-2 spike peptide predicted binding

*Charles Schutt1, Deren Birol1, Xiuyuan Lu1, Sho Yamasaki1,2,3 (1. Immunology Frontier Research Center (IFReC), The University of Osaka (Japan), 2. Research Institute for Microbial Diseases (RIMD), The University of Osaka (Japan), 3. Center for Infectious Disease Education and Research (CiDER), The University of Osaka (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in